DUBLIN, Ireland, July 19, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that it will issue a press release detailing its second quarter 2013 financial results after the market close on Wednesday, July 24, 2013.

Although the Company will not be hosting a quarterly conference call, investors and other interested parties may access the press release by visiting http://ir.wcrx.com and clicking on Press Releases. 

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, urology and dermatology segments of the branded pharmaceuticals market, primarily in North America.  We are a fully integrated company with internal resources dedicated to the development, manufacture and promotion of our products. 


CONTACT: Rochelle Fuhrmann

         Senior Vice President, Finance

         973-442-3281

         rfuhrmann@wcrx.com

         

         Kevin Crissey

         Director, Investor Relations

         973-907-7084

         Kevin.Crissey@wcrx.com
distributed by